Home Companies Newleos COMPANY
Clinical Phase 2
Company-reported stage: Phase 1b · source · Oct 12, 2026
1 open job · last seen Oct 23, 2026 · 3 sources
Location: Boston, MA · source · Oct 13, 2026
Profile checked Oct 10, 2026
Keywords: Dup15Q Syndrome Social Anxiety Disorder Alcohol Use Disorder NTX-1472 NTX-2001
At a glance HQ Boston, MA source Stage Clinical Phase 2 Latest trial II: A Phase II Study of Basmisanil in Children and Adolescents With Dup15q Syndrome (Dec 1, 2026) source Timeline Dec 1, 2026 Trial start II: A Phase II Study of Basmisanil in Children and Adolescents With Dup15q Syndrome source ↗ Mar 20, 2026 Trial start Phase 1: Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder source ↗ Dec 9, 2025 Trial start Phase 2: A Study of NTX-1472 in Social Anxiety Disorder source ↗ Upcoming milestones 2027-01 (ESTIMATED) · Phase 2 · A Study of NTX-1472 in Social Anxiety Disorder · NCT07323784 2027-03 (ESTIMATED) · Phase 1 · Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder · NCT07520292 May 1, 2029 (ESTIMATED) · II · A Phase II Study of Basmisanil in Children and Adolescents With Dup15q Syndrome · NCT07846215 Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 3 Record Title Phase Status Start Primary completion NCT07846215 A Phase II Study of Basmisanil in Children and Adolescents With Dup15q Syndrome II Not yet recruiting Dec 1, 2026 May 1, 2029 (estimated) NCT07323784 A Study of NTX-1472 in Social Anxiety Disorder Phase 2 Recruiting Dec 9, 2025 2027-01 (estimated) NCT07520292 Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder Phase 1 Recruiting Mar 20, 2026 2027-03 (estimated)
Open jobs 1 Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.
